Next Article in Journal
A Review of Eight High-Priority, Economically Important Viral Pathogens of Poultry within the Caribbean Region
Next Article in Special Issue
Intrauterine Transmission of Anaplasma phagocytophilum in Persistently Infected Lambs
Previous Article in Journal
Molecular Identification of Eimeria Species in Broiler Chickens in Trinidad, West Indies
Article Menu
Issue 1 (March) cover image

Export Article

Open AccessFeature PaperArticle
Vet. Sci. 2018, 5(1), 13;

Development of an Indirect ELISA Based on a Recombinant Chimeric Protein for the Detection of Antibodies against Bovine Babesiosis

Instituto de Biotecnología, Centro de Investigaciones en Ciencias Veterinarias y Agronómicas, Instituto Nacional de Tecnología Agropecuaria, De Los Reseros y Dr. Nicolás Repetto s/no., Hurlingham 1686, Buenos Aires, Argentina
Estación Experimental Agropecuaria Mercedes, Instituto Nacional de Tecnología Agropecuaria, Juan Pujol al Este, s/n, Corrientes CP 3470, Argentina
Author to whom correspondence should be addressed.
Received: 19 December 2017 / Revised: 19 January 2018 / Accepted: 21 January 2018 / Published: 23 January 2018
Full-Text   |   PDF [869 KB, uploaded 23 January 2018]   |  


The current method for Babesia spp. serodiagnosis based on a crude merozoite antigen is a complex and time-consuming procedure. An indirect enzyme-linked immunosorbent assay (iELISA) based on a recombinant multi-antigen of Babesia bovis (rMABbO) was developed for detection of antibodies in bovines suspected of infection with this parasite. The multi-antigen comprises gene fragments of three previously characterized B. bovis antigens: MSA-2c, RAP-1 and the Heat Shock protein 20 that are well-conserved among geographically distant strains. The cutoff value for the new rMABbo-iELISA was determined using 75 known—positive and 300 known—negative bovine sera previously tested for antibodies to B. bovis by the gold-standard ELISA which uses a merozoite lysate. A cutoff value of ≥35% was determined in these samples by receiver operator characteristic (ROC) curve analysis, showing a sensitivity of 95.9% and a specificity of 94.3%. The rMABbo-iELISA was further tested in a blind trial using an additional set of 263 field bovine sera from enzootic and tick-free regions of Argentina. Results showed a good agreement with the gold standard test with a Cohen’s kappa value of 0.76. Finally, the prevalence of bovine babesiosis in different tick enzootic regions of Argentina was analyzed where seropositivity values among 68–80% were obtained. A certain level of cross reaction was observed when samples from B. bigemina infected cattle were analyzed with the new test, which can be attributed to shared epitopes between 2 of the 3 antigens. This new rMABbo-iELISA could be considered a simpler alternative to detect anti Babesia spp. antibodies and appears to be well suited to perform epidemiological surveys at the herd level in regions where ticks are present. View Full-Text
Keywords: bovine babesiosis; multi-epitope recombinant antigen; indirect ELISA; seroprevalence bovine babesiosis; multi-epitope recombinant antigen; indirect ELISA; seroprevalence

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Jaramillo Ortiz, J.M.; Montenegro, V.N.; de la Fournière, S.A.M.; Sarmiento, N.F.; Farber, M.D.; Wilkowsky, S.E. Development of an Indirect ELISA Based on a Recombinant Chimeric Protein for the Detection of Antibodies against Bovine Babesiosis. Vet. Sci. 2018, 5, 13.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Vet. Sci. EISSN 2306-7381 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top